The journal of headache and pain 2026 Jun 13. doi: 10.1186/s10194-026-02423-x. Online ahead of print. Henrik W Schytz , Rigmor H Jensen , Christofer Lundqvist , Cristina Tassorelli , Fabrizio Vernieri , Michel Lantéri-Minet , Gisela M Terwindt , Andrew Blumenfeld , Stewart J Tepper , Mette Krog Josiassen , Gary
Benefits of eptinezumab on patient-reported disease burden and health-related quality of life in adults with chronic migraine and medication-overuse headache: Results from the placebo-controlled RESOLUTION trial
Cephalalgia Stewart J Tepper , Henrik W Schytz , Rigmor H Jensen , Christofer Lundqvist , Gisela M Terwindt , Cristina Tassorelli , Fabrizio Vernieri , Michel Lantéri-Minet , Andrew Blumenfeld , Mette Krog Josiassen , Gary Jansson , Anders Ettrup , Aurélia Mittoux , Richard B Lipton Abstract AimThe phase 4 RESOLUTION
Migraine-related disability according to headache frequency subclassifications: A systematic review and meta-analysis
Cephalalgia 2025 Oct;45(10):3331024251385965. doi: 10.1177/03331024251385965. Epub 2025 Oct 17. Manjit Singh Matharu , Stephen Silberstein , Hsiangkuo Yuan , Deborah Edgar 3 Roos Colman , Todd J Schwedt , Michel Lanteri-Minet , Mark Obermann Abstract BackgroundThis systematic review and meta-analysis synthesized migraine-related disability outcomes according to headache frequency subclassifications,